Clinical trials sponsored by H. Lundbeck A/S

Phase breakdown

Conditions studied

Recruiting trials led by H. Lundbeck A/S

• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
  NCT04965675 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 83 locations
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
  NCT05164172 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 70 locations
• A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
  NCT05897320 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 62 locations
• A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
  NCT07513441 · Phase: Phase 1 · Ages: 35 Years to 85 Years · Sex: All (male and female) · 4 locations

Common questions

How many trials is H. Lundbeck A/S recruiting for?

H. Lundbeck A/S is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.